Skip to main content
      RT @AurelieRheumo: Don’t forget to detect cardiac abnormalities in your #RA and #PsA patients! Systematic transthoraci

      Aurelie Najm AurelieRheumo

      4 years 5 months ago
      Don’t forget to detect cardiac abnormalities in your #RA and #PsA patients! Systematic transthoracic echocardiogram show higher prevalence of diastolic dysfunction, mild mitral and pulmonary valve regurgitation vs. matched controls. #EULAR2021 @RheumNow #POS1392 https://t.co/UsvbEKBRUY
      RT @AurelieRheumo: Result from the #EULAR2021 recommendations on management of RMD in COVID update SLR: No evidence that

      Aurelie Najm AurelieRheumo

      4 years 5 months ago
      Result from the #EULAR2021 recommendations on management of RMD in COVID update SLR: No evidence that people with RMDs present an increased risk of contracting COVID19, consistent with the initial Recos. @RheumNow https://t.co/2Q0s3ZKJOP
      RT @ERheumat: 🚨So after LoVAS
      Now this
      Ritux + MMF + Pulse MPS
      No oral steroids 🤯
      @ARD_BMJ
      @EBRheum - Lesser i

      EnvisionRheumat ERheumat

      4 years 5 months ago
      🚨So after LoVAS Now this Ritux + MMF + Pulse MPS No oral steroids 🤯 @ARD_BMJ @EBRheum - Lesser is better ?? https://t.co/CYMNX8wLtd https://t.co/NtwTas3ZdS
      RT @ejdein1: Oh, this is a bummer. #EULAR2021 @RheumNow https://t.co/abdEXPU3Bh

      Eric Dein ejdein1

      4 years 5 months ago
      Oh, this is a bummer. #EULAR2021 @RheumNow https://t.co/abdEXPU3Bh
      RT @RichardPAConway: Dr Atienza-Mateo presents on IFX ADA TCZ in Behcets refractory uveitic cystoid macular oedema. All

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Atienza-Mateo presents on IFX ADA TCZ in Behcets refractory uveitic cystoid macular oedema. All appear effective! @RheumNow #EULAR2021 Abstr#OP0060 https://t.co/Vpju0IvrC5
      RT @RichardPAConway: Dr Mekinian presents data showing TCZ and TNFi appear equally effective in TAK, complete response 6

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Mekinian presents data showing TCZ and TNFi appear equally effective in TAK, complete response 66% vs 70% at 6 months @RheumNow #EULAR2021 Abstr#OP0068
      RT @RichardPAConway: Dr Kragsnaes presents counter-intuitive data on the gut microbiome. Faecal microbiota transplant in

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Kragsnaes presents counter-intuitive data on the gut microbiome. Faecal microbiota transplant ineffective in treating active peripheral psoriatic arthritis, leading to WORSE outcomes. But maybe this also tells us something? @RheumNow #EULAR2021 Abstr#OP0010 https://t.co/nvDvO4Gfxc
      RT @Yuz6Yusof: Promising preclinical data of novel dual BAFF/APRIL inihibitor ALPN-303 re:efficacy & immunomodulator

      Md Yuzaiful Md Yusof Yuz6Yusof

      4 years 5 months ago
      Promising preclinical data of novel dual BAFF/APRIL inihibitor ALPN-303 re:efficacy & immunomodulatory activity vs TACI-i. Could deplete plasma cell compared to anti-CD20 mAbs in #SLE. Be interesting to see how it’ll fare in future clinical trials #EULAR2021 #OP0039 @RheumNow https://t.co/LnQzO67gwI
      RT @RichardPAConway: Dr Sanchez-Bilbao presents surprising data that tocilizumab may improve even permanent vision loss

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Sanchez-Bilbao presents surprising data that tocilizumab may improve even permanent vision loss in GCA @RheumNow #EULAR2021 Abstr#OP0065 https://t.co/oFGNZ04oKr
      RT @ejdein1: ProDERM OP0008: IVIG 2g/kg q4w for dermatomyositis vs PBO, open-label extension. TIS score responders 78% v

      Eric Dein ejdein1

      4 years 5 months ago
      ProDERM OP0008: IVIG 2g/kg q4w for dermatomyositis vs PBO, open-label extension. TIS score responders 78% vs 43%. IVIG great option: Not immunosuppressive and works fast, watch for headache, pyrexia, nausea, risk of VTE. #EULAR2021 @RheumNow https://t.co/m4CEkg3EyC
      RT @ejdein1: We know smoking is ass w/ RA. How about passive 🚬? French E3N-EPIC cohort: OP0012. Prospective questiona

      Eric Dein ejdein1

      4 years 5 months ago
      We know smoking is ass w/ RA. How about passive 🚬? French E3N-EPIC cohort: OP0012. Prospective questionaries of 80,000F, 698 incident cases. ⬆️ risk in passive childhood and adult tobacco exposure. #EULAR2021 @RheumNow 🚭! https://t.co/1Rf0euz3VC
      RT @ejdein1: OP0010 at #EULAR2021. FLORA trial: Fecal microbiota transplant as add-on Rx to MTX. Small trial showing tim

      Eric Dein ejdein1

      4 years 5 months ago
      OP0010 at #EULAR2021. FLORA trial: Fecal microbiota transplant as add-on Rx to MTX. Small trial showing time-to-event curves show inferiority to sham but good safety. Fascinating concept exploring gut-joint interaction. @RheumNow. https://t.co/BIOmA5z6vK
      RT @drdavidliew: Some interesting abstracts at #EULAR2021 today on monitoring GCA with:
      - ultrasound
      OP0055 https://t.co

      David Liew drdavidliew

      4 years 5 months ago
      Some interesting abstracts at #EULAR2021 today on monitoring GCA with: - ultrasound OP0055 https://t.co/0fqLIK5IPV - PET/CT OP0069 https://t.co/WQl9VaHR9E OP0064 https://t.co/w7biFT6qy0 What do you believe is the most accurate measure of true disease activity in GCA? @RheumNow
      RT @RichardPAConway: Dr Arnold @Yuz6Yusof present on personalised rituximab retreatment in AAV. Interesting that naive B

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Arnold @Yuz6Yusof present on personalised rituximab retreatment in AAV. Interesting that naive B-cell repopulation at 6 months predicts better sustained response compared to absence @RheumNow #EULAR2021 Abstr#OP0057 https://t.co/cypyQVMeYz
      ×